AIM ImmunoTech Inc (AIM)
0.2101
0.00 (0.00%)
USD |
NYAM |
Nov 22, 16:00
0.21
0.00 (0.00%)
After-Hours: 20:00
AIM ImmunoTech Free Cash Flow: -21.33M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -21.33M |
| June 30, 2024 | -23.91M |
| March 31, 2024 | -23.04M |
| December 31, 2023 | -21.85M |
| September 30, 2023 | -18.14M |
| June 30, 2023 | -17.27M |
| March 31, 2023 | -17.27M |
| December 31, 2022 | -16.38M |
| September 30, 2022 | -16.04M |
| June 30, 2022 | -14.59M |
| March 31, 2022 | -13.98M |
| December 31, 2021 | -14.60M |
| September 30, 2021 | -11.84M |
| June 30, 2021 | -11.29M |
| March 31, 2021 | -11.01M |
| December 31, 2020 | -10.96M |
| September 30, 2020 | -10.21M |
| June 30, 2020 | -9.782M |
| March 31, 2020 | -11.20M |
| December 31, 2019 | -9.432M |
| September 30, 2019 | -9.479M |
| June 30, 2019 | -9.946M |
| March 31, 2019 | -9.806M |
| December 31, 2018 | -10.77M |
| September 30, 2018 | -9.109M |
| Date | Value |
|---|---|
| June 30, 2018 | -7.994M |
| March 31, 2018 | -7.559M |
| December 31, 2017 | -8.01M |
| September 30, 2017 | -9.351M |
| June 30, 2017 | -10.49M |
| March 31, 2017 | -9.736M |
| December 31, 2016 | -7.834M |
| September 30, 2016 | -9.11M |
| June 30, 2016 | -9.556M |
| March 31, 2016 | -13.20M |
| December 31, 2015 | -16.54M |
| September 30, 2015 | -17.38M |
| June 30, 2015 | -17.78M |
| March 31, 2015 | -16.14M |
| December 31, 2014 | -14.73M |
| September 30, 2014 | -13.97M |
| June 30, 2014 | -14.35M |
| March 31, 2014 | -14.94M |
| December 31, 2013 | -18.04M |
| September 30, 2013 | -20.56M |
| June 30, 2013 | -20.67M |
| March 31, 2013 | -22.03M |
| December 31, 2012 | -19.10M |
| September 30, 2012 | -17.23M |
| June 30, 2012 | -15.61M |
Free Cash Flow Range, Past 5 Years
-23.91M
Minimum
Jun 2024
-9.432M
Maximum
Dec 2019
-15.21M
Average
-14.59M
Median
Free Cash Flow Benchmarks
| Perspective Therapeutics Inc | -40.58M |
| Protalix BioTherapeutics Inc | 7.171M |
| Electromed Inc | 11.30M |
| Xtant Medical Holdings Inc | -17.28M |
| Armata Pharmaceuticals Inc | -42.09M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.11M |
| Cash from Investing (Quarterly) | 0.334M |
| Cash from Financing (Quarterly) | 0.137M |
| Free Cash Flow Per Share (Quarterly) | -0.0567 |
| Free Cash Flow to Equity (Quarterly) | -3.363M |
| Free Cash Flow Yield | -194.4% |